Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 152

Sort by

Sort Order Select

Journal Articles

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD

Ying Wang, Shan He, Gennaro Calendo, Tien Bui, Yuanyuan Tian, Che Young Lee, Yan Zhou, Xin Zhao, Ciril Abraham, Wenbin Mo, Mimi Chen, Ruqayyah Sanders-Braggs, Jozef Madzo, Jean-Pierre Issa, Elizabeth O. Hexner, David L. Wiest, Ran Reshef, Hai-Hui Xue, Yi Zhang

Blood (2024) 143 (2): 166–177.

https://doi.org/10.1182/blood.2023021126

Published: 2024

Includes: Supplemental data

Journal Articles

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

Blood (2023) 142 (Supplement 1): 827.

https://doi.org/10.1182/blood-2023-184421

Published: 2023

Journal Articles

Remote Blood Hemoglobin Monitoring with Hyperspectral Color Truthing for Advancing Sickle Cell Care

Sang Mok Park, Yuhyun Ji, Semin Kwon, Jung Woo Leem, Andrew Ross Wickman O'Brien, Ying Wang, Young L Kim

Blood (2023) 142 (Supplement 1): 2277.

https://doi.org/10.1182/blood-2023-190659

Published: 2023

Journal Articles

Patient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia

Kah Poh (Melissa) Loh, Soroush Mortaz-Hedjri, Ying Wang, Marissa Locastro, Sally Norton, Jason H. Mendler, Jane L. Liesveld, Eric J Huselton, Marielle Jensen-Battaglia, Kathryn Buettner, Jenae Davis, Heidi Klepin, Daniel R. Richardson

Blood (2023) 142 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2023-172827

Published: 2023

Journal Articles

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

Anli Lai, Hui Wei, Ying Wang, Dong Lin, Chunlin Zhou, Bingcheng Liu, Runxia Gu, Yan Li, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Junping Zhang, Yingchang Mi, Shaowei Qiu, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5988.

https://doi.org/10.1182/blood-2023-179966

Published: 2023

Journal Articles

Sitagliptin for Prevention of aGVHD in Patients Received Alternative Donor Transplantations: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial

Man Qiao, Xiaofei Yang, Xiebing Bao, Jihao Zhou, Han Zhu, Yanming Zhang, Tao You, Huiying Qiu, Ying Wang, Shengli Xue, Aining Sun, Yue Han, Xiao Ma, Xiaojin Wu, Depei Wu, Suning Chen

Blood (2023) 142 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2023-189348

Published: 2023

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

Strategies in Recruitment and Retention of Patients with Sickle Cell Disease for a Single-Site Longitudinal Clinical Trial

Persis Ayeh, Siddhi Naresh Gandhi, Charanjit Kaur, Veena Vijayan, Anne Amegbeha, Andrew Pucka, Andrew Ross Wickman O'Brien, Steven E Harte, Richard E Harris, Ying Wang

Blood (2023) 142 (Supplement 1): 2306.

https://doi.org/10.1182/blood-2023-187907

Published: 2023

Journal Articles

Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

David M. Kurtz, Gregory Hogan, Andre Schultz, Jacob J. Chabon, Ash A. Alizadeh, Karin Havenith, Sara Samari, Tim Kopotsha, Luqiang Wang, Yajuan Qin, Ying Wang, Serafino Pantano

Blood (2023) 142 (Supplement 1): 3133.

https://doi.org/10.1182/blood-2023-179977

Published: 2023

Journal Articles

Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia

Sining Liu, Qingya Cui, Zheng Li, Wei Cui, Mengyun Li, Huiying Qiu, Shengli Xue, Suning Chen, Zhengming Jin, Miao Miao, Yue Han, Ying Wang, Xiaming Zhu, Lei Yu, Depei Wu, Xiaowen Tang

Blood (2023) 142 (Supplement 1): 3491.

https://doi.org/10.1182/blood-2023-186718

Published: 2023

Journal Articles

A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial

Huiying Qiu, Qiaomei He, Xi Sun, Ying Wang, Jiahua Niu, Jun Yang, Chongmei Huang, Kun Zhou, Yin Tong, Yu Cai, Baoxia Dong, Liping Wan, Xianmin Song

Blood (2023) 142 (Supplement 1): 3554.

https://doi.org/10.1182/blood-2023-189174

Published: 2023

Journal Articles

Dual Functions of Mitochondrial Calcium Uniporter in T Cell Alloimmunity

Ying WANG, Alicia Huaze Li, Ruqayyah sanders-Braggs, Yan Zhou, Mimi Chen, Tien Bui, Hongfa Zhu, Jonathan Soboloff, John Elrod, Elizabeth O Hexner, Yi Zhang

Blood (2023) 142 (Supplement 1): 4787.

https://doi.org/10.1182/blood-2023-190563

Published: 2023

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

Telehealth Serious Illness Care Program for Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Single-Arm Pilot Study

Marissa Locastro, Soroush Mortaz-Hedjri, Ying Wang, Jason H. Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi Klepin, Jane L. Liesveld, Eric J Huselton, Benzi Kluger, Kah Poh Loh

Blood (2023) 142 (Supplement 1): 260.

https://doi.org/10.1182/blood-2023-174563

Published: 2023

Journal Articles

Identifying Inflammatory and Immune Markers Associated with Vasoocclusive Crisis in Patients with Sickle Cell Disease

Wei Li, Andrew Pucka, Candice Debats, Brandon Reyes, Andrew Ross Wickman O'Brien, Qigui Yu, Ying Wang

Blood (2023) 142 (Supplement 1): 3868.

https://doi.org/10.1182/blood-2023-187588

Published: 2023

Journal Articles

TIF1γ Counteracts Ferroptosis to Drive Erythroid Progenitor Differentiation

Marlies P. Rossmann, Song Yang, Brian J. Abraham, Ying Wang, Richard A. Young, Siegfried Hekimi, Leonard I. Zon

Blood (2023) 142 (Supplement 1): 8.

https://doi.org/10.1182/blood-2023-184853

Published: 2023

Journal Articles

Comparing the Efficacy and Safety of Venetoclax Combined with Decitabine Versus Conventional Chemotherapy As Induction Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia - Interim Analysis of a Multicenter, Randomized, Phase 2b Trial

Jing Lu, Shengli Xue, Ying Wang, Hai-Ping Dai, Xuefeng He, Xiaohui Hu, Miao Miao, Huiying Qiu, Han Yue, Caixia Li, Depei Wu, Suning Chen

Blood (2023) 142 (Supplement 1): 970.

https://doi.org/10.1182/blood-2023-181347

Published: 2023

Journal Articles

Efficacy and Safety of Interleukin-6-Knockdown CD19-Targeted CAR T Cells(ssCART-19) for Relapsed/Refractory B-ALL

Blood (2023) 142 (Supplement 1): 889.

https://doi.org/10.1182/blood-2023-172615

Published: 2023

Journal Articles

Gene-Edited Universal CD7 Chimeric Antigen Receptor T Cells for Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Fang Liu, Ye Guo, Wenyu Yang, Ying Wang, Xiaofan Zhu

Blood (2023) 142 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2023-185754

Published: 2023

Journal Articles

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

Blood (2023) 142 (Supplement 1): 4335.

https://doi.org/10.1182/blood-2023-184432

Published: 2023

NARROW

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

Remote Blood Hemoglobin Monitoring with Hyperspectral Color Truthing for Advancing Sickle Cell Care

Patient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

Sitagliptin for Prevention of aGVHD in Patients Received Alternative Donor Transplantations: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Strategies in Recruitment and Retention of Patients with Sickle Cell Disease for a Single-Site Longitudinal Clinical Trial

Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia

A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial

Dual Functions of Mitochondrial Calcium Uniporter in T Cell Alloimmunity

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Telehealth Serious Illness Care Program for Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Single-Arm Pilot Study

Identifying Inflammatory and Immune Markers Associated with Vasoocclusive Crisis in Patients with Sickle Cell Disease

TIF1γ Counteracts Ferroptosis to Drive Erythroid Progenitor Differentiation

Comparing the Efficacy and Safety of Venetoclax Combined with Decitabine Versus Conventional Chemotherapy As Induction Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia - Interim Analysis of a Multicenter, Randomized, Phase 2b Trial

Efficacy and Safety of Interleukin-6-Knockdown CD19-Targeted CAR T Cells(ssCART-19) for Relapsed/Refractory B-ALL

Gene-Edited Universal CD7 Chimeric Antigen Receptor T Cells for Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only